Compile Data Set for Download or QSAR
Report error Found 56 Enz. Inhib. hit(s) with all data for entry = 50047929
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197573(CHEMBL3912764)
Affinity DataIC50: 3nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197580(CHEMBL3933831)
Affinity DataIC50: 12nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197528(CHEMBL3917216)
Affinity DataIC50: 26nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins in presence of 1% human serum albumin by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197541(CHEMBL3949673)
Affinity DataIC50: 38nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins in presence of 1% human serum albumin by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197542(CHEMBL3967145)
Affinity DataIC50: 49nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins in presence of 1% human serum albumin by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197526(CHEMBL3982647)
Affinity DataIC50: 51nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins in presence of 1% human serum albumin by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197549(CHEMBL3922450)
Affinity DataIC50: 69nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197565(CHEMBL3937445)
Affinity DataIC50: 71nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197576(CHEMBL3961311)
Affinity DataIC50: 81nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197526(CHEMBL3982647)
Affinity DataIC50: 123nMAssay Description:Inhibition of activated TAFI in human blood by clot lysis assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197578(CHEMBL3919256)
Affinity DataIC50: 130nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197557(CHEMBL3968851)
Affinity DataIC50: 170nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197556(CHEMBL3953898)
Affinity DataIC50: 170nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197543(CHEMBL3955010)
Affinity DataIC50: 200nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins in presence of 1% human serum albumin by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197536(CHEMBL3982584)
Affinity DataIC50: 220nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins in presence of 1% human serum albumin by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197555(CHEMBL3900483)
Affinity DataIC50: 230nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197533(CHEMBL3977342)
Affinity DataIC50: 330nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins in presence of 1% human serum albumin by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197575(CHEMBL3893656)
Affinity DataIC50: 360nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197559(CHEMBL3948097)
Affinity DataIC50: 400nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197570(CHEMBL3939311)
Affinity DataIC50: 420nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197540(CHEMBL3926028)
Affinity DataIC50: 490nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins in presence of 1% human serum albumin by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197550(CHEMBL3921361)
Affinity DataIC50: 670nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197572(CHEMBL3917119)
Affinity DataIC50: 880nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197531(CHEMBL3949183)
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins in presence of 1% human serum albumin by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197558(CHEMBL3928428)
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197574(CHEMBL3945165)
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197579(CHEMBL3956045)
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197564(CHEMBL3927290)
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197560(CHEMBL3894238)
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197562(CHEMBL3930326)
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197544(CHEMBL3975632)
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins in presence of 1% human serum albumin by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197539(CHEMBL3906963)
Affinity DataIC50: 2.10E+3nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins in presence of 1% human serum albumin by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197552(CHEMBL3966078)
Affinity DataIC50: 2.30E+3nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197563(CHEMBL3963543)
Affinity DataIC50: 4.40E+3nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197534(CHEMBL3905126)
Affinity DataIC50: 5.70E+3nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins in presence of 1% human serum albumin by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197553(CHEMBL3981469)
Affinity DataIC50: 6.40E+3nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197561(CHEMBL3985242)
Affinity DataIC50: 6.70E+3nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197545(CHEMBL3945036)
Affinity DataIC50: 7.10E+3nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins in presence of 1% human serum albumin by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197566(CHEMBL3952628)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
LigandPNGBDBM50197526(CHEMBL3982647)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human ERG expressed in CHO cells by patch clamp methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197526(CHEMBL3982647)
Affinity DataIC50: 1.20E+4nMAssay Description:Inhibition of CYP3A4 in human liver microsomes using midazolam as substrate assessed as suppression of 1'-hydroxymidazolam formation after 10 mins by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197527(CHEMBL3977994)
Affinity DataIC50: 1.50E+4nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins in presence of 1% human serum albumin by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197577(CHEMBL3934198)
Affinity DataIC50: 2.40E+4nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197529(CHEMBL3944308)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins in presence of 1% human serum albumin by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197535(CHEMBL3892421)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins in presence of 1% human serum albumin by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197537(CHEMBL3924916)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins in presence of 1% human serum albumin by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197526(CHEMBL3982647)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of CYP3A4 in human liver microsomes using midazolam as substrate assessed as suppression of 1'-hydroxymidazolam formation after 10 mins by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197538(CHEMBL3915923)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins in presence of 1% human serum albumin by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197568(CHEMBL3972493)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
TargetCarboxypeptidase B2(Human)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50197546(CHEMBL3910436)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins in presence of 1% human serum albumin by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2018
Entry Details Article
PubMed
Displayed 1 to 50 (of 56 total ) | Next | Last >>
Jump to: